Central nervous system blockade by peripheral administration of AT1 receptor blockers

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 4, 2003, Pages 593-599

  Wang, Jun Ming ^a   Tan, Junhui ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

AT1 receptor blockers; Blood; Brain AT1 receptors; Brain barrier; Central blockade

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; EMBUSARTAN; IODINE 125; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; LOSARTAN; MALE; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0037380939     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200304000-00012     Document Type: Article

References (20)

1. Allen AM, MacGregor DP, McKinley MJ, et al. Angiotensin II receptors in the human brain. Regul Pept 1999;79:1-7.
2. de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-72.
3. Huang BS, Leenen FHH. Brain "ouabain" and angiotensin II in saltsensitive hypertension in spontaneously hypertensive rats. Hypertension 1996;28:1005-12.
4. Huang BS, Leenen FHH. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 1998;32:1028-33.
5. Leenen FHH, Yuan B, Huang BS. Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol 1999;46:H1786-92.
6. Bui JD, Kimura B, Phillips MI. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier. Eur J Pharmacol 1992;219:147-51.
7. Wong PC, Price WA Jr, Chiu AT, et al. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;255:211-7.
8. Culman J, von Heyer C, Piepenburg B, et al. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. Eur J Pharmacol 1999;367:255-65.
9. Gohlke P, Weiss S, Jansen A, et al. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther 2001;298:62-70.
10. Zhang J, Leenen FHH. AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am J Physiol Heart Circ Physiol 2001;280:H1318-23.
11. Leenen FHH, Yuan B. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Hypertension 2001;37:981-4.
12. Song KF, Zhuo JL, Mendelsohn FA. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. Br J Pharmacol 1991;104:771-2.
13. Zhuo J, Song K, Abdelrahman A, et al. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 1994;21:557-67.
14. Muders F, Palkovits M, Bahner U, et al. Central inhibition of AT1receptors by eprosartan-in vitro autoradiography in the brain. Pharmacol Res 2001;43:251-5.
15. Morsing P, Adler G, Brandt-Eliasson U, et al. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999;33:1406-13.
16. Nishimura Y, Ito T, Hoe K, et al. Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors. Brain Res 2000;871:29-38.
17. Paxinos GA, Watson WC. The Rat Brain in Stereotaxic Coordinates. 2nd ed. San Diego: Academic Press, 1986.
18. Budzikowski AS, Leenen FHH. ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR. Am J Physiol Heart Circ Physiol 2001;281:H1210-6.
19. Bartus RT, Elliott PJ, Dean RL, et al. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp Neurol 1996; 142:14-28.
20. Murakami H, Takanaga H, Matsuo H, et al. Comparison of bloodbrain barrier permeability in mice and rats using in situ brain perfusion technique. Am J Physiol Heart Circ Physiol 2000;279:H1022-8.